Longevity Angitia Bio lands $130m to advance human trials of musculoskeletal health drugsBy adminFebruary 8, 20260 Company’s osteoporosis program completes enrollment in Phase 2 trial focused on treating the disease in postmenopausal women. US biotech Angitia…
DNA & Genetics Chai’s the Limit for AI Antibody Designer After $130M Series B FundingBy adminDecember 17, 20250 Chai Discovery has completed a $130 million Series B financing that the artificial intelligence (AI)-based de novo antibody designer says…
